Reduced temperature sterilization of stents
US-9339568-B2 · May 17, 2016 · US
US9682162B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9682162-B2 |
| Application number | US-201414153477-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 13, 2014 |
| Priority date | Aug 15, 2006 |
| Publication date | Jun 20, 2017 |
| Grant date | Jun 20, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of sterilizing medical devices, including implantable medical devices like stents, chemically and with radiation are disclosed. Methods of preparing a sterile, packaged medical device, including a sterile, packaged implantable medical device or stent are disclosed.
Opening claim text (preview).
What is claimed is: 1. A method for preparing a sterilized packaged stent, the method comprising: exposing a stent comprising a polymer to radiation to sterilize the stent while the stent is in an uncrimped state; after exposing the stent to radiation to sterilize the stent, coating the stent aseptically; and packaging the coated stent to form the sterilized packaged stent. 2. The method of claim 1 , wherein the stent is exposed to radiation to sterilize the stent prior to mounting the stent on a delivery device. 3. The method of claim 1 , further comprising mounting the coated stent onto a delivery device. 4. The method of claim 1 , further comprising performing one or more additional stent processing operations, wherein all of the one or more stent processing operations subsequent to the exposure of the stent to radiation to sterilize the stent are performed aseptically. 5. The method of claim 1 , wherein the sterilization is electron beam sterilization. 6. The method of claim 1 , wherein the polymer is selected from the group consisting of poly(N-acetylglucosamine) (Chitin), Chitosan, poly(3-hydroxyvalerate), poly(lactide-co-glycolide), poly(-hydroxybutyrate), poly(-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate), polyorthoesters, polyanhydrides, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D,L-lactic acid), poly(D,L-lactide), poly(L-lactide-co-D,L-lactide), poly(caprolactone), poly(L-lactide-co-caprolactone), poly(D,L-lactide-co-caprolactone), poly(glycolide-co-caprolactone), poly(trimethylene carbonate), polyester amides, poly(glycolic acid-co-trimethylene carbonate), co-poly(ether-esters) (e.g. PEO/PLA), polyphosphazenes, fibrin, fibrinogen, cellulose, starch, collagen, hyaluronic acid, polyurethanes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers and copolymers, polyvinyl chloride, polyvinyl ethers, polyvinyl methyl ether, polyvinylidene halides, polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, polystyrene, polyvinyl esters, acrylonitrile-styrene copolymers, acrylonitrile butadiene styrene resins, polyamides, Nylon 66, polycaprolactam, polycarbonates, polyoxymethylenes, polyimides, polyethers, rayon, rayon-triacetate, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, carboxymethyl cellulose, ethylene vinyl alcohol copolymer, poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluoropropene), polyvinylidene fluoride, ethylene-vinyl acetate copolymers, poly(vinyl acetate), styrene-isobutylene-styrene triblock copolymers, polyethylene glycol, and combinations thereof. 7. The method of claim 1 , wherein the stent further comprises a drug. 8. The method of claim 1 , wherein the stent further comprises a bioactive agent. 9. The method of claim 1 , wherein the stent further comprises a protein. 10. The method of claim 1 , wherein the stent further comprises a macromolecule.
Containers other than laboratory or medical, e.g. bottles or mail · CPC title
Laboratory, medical or dentistry appliances, e.g. catheters or sharps · CPC title
Packages or dispensers for prostheses or other implants (for intraocular lenses A61F2/1691; for dental surgery A61C19/02) · CPC title
Human Necessities · mapped topic
Radiation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.